Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBrigitta Rasmussen Villumsen

About this trial

The goal of this observational study is to gather real-world information about Fear of Cancer Recurrence (FCR) following surgery in patients with renal cell carcinoma (RCC) and their partners/spouses by 1) establishing a panel consisting of patients with or without partners/spouses to facilitate patient-partnered research. Furthermore, 2) Through discussions among panel members and researchers identification of the most pertinent topics related to FCR, as well as the optimal timing and methods for collecting that information in the follow-up care after surgery. Finally, to conduct a feasibility and pilot study to investigate the feasibility of the recommendations developed in 1) + 2) and assess FCR in patients with RCC following surgery and their partners/spouses.

In phase 1 participants (panel members) will be asked to collaborate with researchers in the development of recommendations for FCR questions, mode of administration and timing in the follow-up care after surgically treated kidney cancer.

In phase 2 participants (patients and partners) in follow-up care after surgically treated kidney cancer are asked to answer questions about FCR at specific timepoints defined by panel members and researchers in phase 1.

Eligibility criteria

Qualifiers

Single patients diagnosed with Renal Cell Carcinoma (RCC) or patients with RCC being in an intimate relationship with a partner/spouse

Partner/spouse to patients who fullfil the inclusion criteria

Patients have undergone surgery due to localized RCC (T1-T2-T3 tumor)

Time since surgery: 0-120 months

Disqualifiers

Diagnosed with cognitive impairment

Untreated psychiatric disorders due to non-compliance

Trial design

Treatments tested in this trial

  • Phase 1: Establishment of a patient-partner panel
  • Phase 2: Feasibility testing of FCR questions, mode of administration and timing for investigating Fear of Cancer Recurrence

Treatment groups

105 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Brigitta Rasmussen Villumsen

Lead sponsor

Gødstrup Hospital

Sponsor institution

Aarhus University Hospital

Collaborator

Aalborg University Hospital

Collaborator